ClinVar Miner

Submissions for variant NM_000057.4(BLM):c.1315A>G (p.Met439Val) (rs201231857)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000574443 SCV000672900 likely benign Hereditary cancer-predisposing syndrome 2017-09-08 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Other strong data supporting benign classification,In silico models in agreement (benign)
GeneDx RCV000115281 SCV000149190 uncertain significance not provided 2014-03-04 criteria provided, single submitter clinical testing Single pathogenic variants in BLM have only recently been described in association with cancer predisposition and the risks are not well understood. This variant is denoted BLM c.1315A>G at the cDNA level, p.Met439Val (M439V) at the protein level, and results in the change of a Methionine to a Valine (ATG>GTG). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. BLM Met439Val was not observed at a significant allele frequency in the NHLBI Exome Sequencing Project. Since Methionine and Valine share similar properties, this is considered a conservative amino acid substitution and is unlikely to affect protein integrity. BLM Met439Val occurs at a position that is highly variable across species and is located in the region necessary for interaction with Scaffolding Protein Involved in DNA Repair- SPIDR- (UniProt). In silico analyses predict that this variant is unlikely to alter protein structure or function. Based on the currently available information, we consider BLM Met439Val to be a variant of uncertain significance. Furthermore, based on the currently available information, cancer risks associated with this variant, and with single variants the BLM gene in general, remain unclear.
GeneKor MSA RCV000574443 SCV000821793 likely benign Hereditary cancer-predisposing syndrome 2018-08-01 criteria provided, single submitter clinical testing
Invitae RCV000234473 SCV000283112 benign Bloom syndrome 2017-12-23 criteria provided, single submitter clinical testing
Mendelics RCV000234473 SCV000838958 uncertain significance Bloom syndrome 2018-07-02 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.